DavidMKushnerMD

Clinical Trials

• Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix Start of enrollment: 2002 Sep 01

  Terminated

  Not Applicable

• Laparoscopic Sentinel Lymph Node Localization in Operable Cervix Cancer Start of enrollment: 2003 Oct 01

  Completed

• Disseminated Endometrial Cancer Cells During Sonohysterography Start of enrollment: 2004 Jan 01

  Completed

  Not Applicable

• Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer Start of enrollment: 2002 Aug 01

  Completed

  Phase 2

• Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer Start of enrollment: 2007 Apr 01

  Completed

  Not Applicable

• Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Start of enrollment: 2008 Feb 25

  Active, not recruiting

  Phase 2

• Sexual Functioning in Endometrial Cancer Start of enrollment: 2007 Oct 01

  Completed

• Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06

  Active, not recruiting

  Phase 3

• Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18

  Recruiting

  Phase 3

• Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13

  Completed

  Phase 2

• Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01

  Unknown status

  Not Applicable

• Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2009 Oct 28

  Completed

  Phase 1

• Evaluation of The Vaginal Renewal™ Program in Gynecologic Cancer Patients Experiencing Sexual Dysfunction Start of enrollment: 2011 Aug 01

  Terminated

  Phase 2

• Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery Start of enrollment: 2011 Sep 01

  Completed

  Phase 2

• Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy Start of enrollment: 2012 Apr 01

  Withdrawn

  Phase 3

• Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer Start of enrollment: 2014 Sep 01

  Completed

  Not Applicable

• Join now to see all